Koga, T., Kobayashi, Y., Tomizawa, K., Suda, K., Kosaka, T., Sesumi, Y., . . . Mitsudomi, T. (2018). Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study. Lung Cancer, 126, 72-79. https://doi.org/10.1016/j.lungcan.2018.10.019

Koga, Takamasa, et al. "Activity of a Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance: An in Vitro Study." Lung Cancer 126 (2018): 72-79. https://doi.org/10.1016/j.lungcan.2018.10.019.

Koga, Takamasa, et al. "Activity of a Novel HER2 Inhibitor, Poziotinib, for HER2 Exon 20 Mutations in Lung Cancer and Mechanism of Acquired Resistance: An in Vitro Study." Lung Cancer, vol. 126, 2018, pp. 72-79, https://doi.org/10.1016/j.lungcan.2018.10.019.